These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2751255

  • 1. Modulation of 5-fluorouracil and 5-fluorouridine toxicity by membrane transport inhibitors in normal tissues of rats with liver adenocarcinoma.
    Jakobsson B, el Hag IA, Erichsen C, Christensson PI, Jönsson PE, Stenram U.
    Anticancer Res; 1989; 9(2):285-90. PubMed ID: 2751255
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incorporation of 5-fluorouracil into RNA of normal tissues and an adenocarcinoma in protein-deprived rats.
    el Hag IA, Jakobsson B, Erichsen C, Christensson PI, Jönsson PE, Stenram U.
    In Vivo; 1987; 1(4):215-20. PubMed ID: 2485132
    [Abstract] [Full Text] [Related]

  • 5. Effect of N-phosphonacetyl-L-aspartate and D-glucosamine on the incorporation of 5-fluorouridine into normal tissues and an adenocarcinoma in the rat.
    Erichsen C, Christensson PI, Jakobsson B, Eriksson G, Yngner T, Jönsson PE, Stenram U.
    Anticancer Res; 1987; 7(1):77-80. PubMed ID: 3566186
    [Abstract] [Full Text] [Related]

  • 6. RNA labelling with 3H-orotic acid and 3H-fluorouracil of rat liver tumour following transient hepatic arterial ischaemia.
    Mack P, Tranberg KG, Strenram U, Jeppsson B, Widlus D, Bengmark S.
    Eur J Surg Oncol; 1988 Dec; 14(6):669-75. PubMed ID: 3192004
    [Abstract] [Full Text] [Related]

  • 7. Potentiation by dipyridamole of 5-fluorouridine antitumor activity against a rat adenocarcinoma in vivo.
    el Hag IA, Roos G, Jönsson PE, Stenram U.
    Anticancer Res; 1990 Dec; 10(1):29-32. PubMed ID: 2139770
    [Abstract] [Full Text] [Related]

  • 8. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
    Plagemann PG, Woffendin C.
    Biochim Biophys Acta; 1988 Apr 02; 969(1):1-8. PubMed ID: 3349106
    [Abstract] [Full Text] [Related]

  • 9. Incorporation of 5-fluorouracil into rat liver tumor and normal tissues and the liver nucleotide profile after administration by the hepatic artery during portal venous branch ligation.
    Jakobsson B, Roos G, el Hag IA, Jönsson PE, Stenram U.
    Res Exp Med (Berl); 1992 Apr 02; 192(1):13-21. PubMed ID: 1570410
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of hepatic artery ligation on the incorporation of 3H-orotic acid into an adenocarcinoma transplanted to rat liver.
    Erichsen C, Christensson PI, Jönsson PE, Stenram U.
    Eur J Surg Oncol; 1986 Jun 02; 12(2):181-6. PubMed ID: 2423375
    [Abstract] [Full Text] [Related]

  • 12. The mechanism of 5-fluorouridine toxicity in Novikoff hepatoma cells.
    Wilkinson DS, Crumley J.
    Cancer Res; 1976 Nov 02; 36(11 Pt 1):4032-8. PubMed ID: 184924
    [Abstract] [Full Text] [Related]

  • 13. The incorporation of 5-fluorouracil into rat liver tumor and normal tissues after administration by the hepatic artery during temporary portal vein clamping.
    el Hag IA, Jakobsson B, Jönsson PE, Stenram U.
    Res Exp Med (Berl); 1990 Nov 02; 190(3):183-92. PubMed ID: 1695018
    [Abstract] [Full Text] [Related]

  • 14. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.
    Shirasaka T, Shimamoto Y, Fukushima M.
    Cancer Res; 1993 Sep 01; 53(17):4004-9. PubMed ID: 7689420
    [Abstract] [Full Text] [Related]

  • 15. Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experience.
    Grem JL.
    Semin Oncol; 1992 Apr 01; 19(2 Suppl 3):56-65. PubMed ID: 1557658
    [Abstract] [Full Text] [Related]

  • 16. Degradable starch microspheres in cytostatic treatment of a liver carcinoma; experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubicin and RSU-1069.
    Roos G, Christensson PI, el Hag IA, Jakobsson B, Teder H, Stenram U.
    Anticancer Res; 1993 Apr 01; 13(3):635-41. PubMed ID: 8317891
    [Abstract] [Full Text] [Related]

  • 17. Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA.
    Benz C, Santos G, Cadman E.
    Cancer Res; 1983 Nov 01; 43(11):5304-8. PubMed ID: 6616465
    [Abstract] [Full Text] [Related]

  • 18. Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liver.
    Lindnér P, Carlsson G, Gustavsson B, Holmberg SB, Naredi P, Peterson A, Hafström L.
    Anticancer Res; 1994 Nov 01; 14(3A):847-52. PubMed ID: 8074485
    [Abstract] [Full Text] [Related]

  • 19. The inhibition of ribosomal RNA synthesis and maturation in Novikoff hepatoma cells by 5-fluorouridine.
    Wilkinson DS, Tlsty TD, Hanas RJ.
    Cancer Res; 1975 Nov 01; 35(11 Pt 1):3014-20. PubMed ID: 171060
    [Abstract] [Full Text] [Related]

  • 20. Calcium leucovorin and 5-fluorouridine cytotoxicity.
    Berger SH, Hakala MT.
    J S C Med Assoc; 1990 May 01; 86(5):284-9. PubMed ID: 2242115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.